Lv1
30 积分 2025-10-18 加入
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial
6天前
已完结
Imaging-based demonstration of plaque regression and stabilization under inclisiran therapy using non-obstructive general angioscopy
7天前
已完结
Inclisiran in addition to statin therapy lowers lipoprotein(a) and improves one-year outcomes in young patients with familial hypercholesterolemia and coronary artery disease
7天前
已完结
Inclisiran in Patients with CKD
1个月前
已完结
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial
1个月前
已完结
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis
2个月前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
4个月前
已完结
In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d
6个月前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
6个月前
已完结
LDL-cholesterol, lipoprotein(a) and high-sensitivity low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events
7个月前
已完结
皖公网安备34019202002308
